Recurrent Lung Cancer - Small Cell


First Targeted Therapy Shows Promise in Small Cell Lung Cancer (June 7, 2016)

Small cell lung cancer (SCLC) accounts for approximately 20–25% of all lung cancers. SCLC is an aggressive and fast-growing type of cancer that is very responsive to chemotherapy. However, although initial... Continue Reading

Lung Cancer Advances: Precision Medicine and Immunotherapy Make a Difference (March 1, 2016)

Precision medicine continues to impact the lives of lung cancer patients with research into genomics and genetics leading to unprecedented progress in improving outcomes. Tailored treatments have emerged... Continue Reading

16th World Conference on Lung Cancer Expected to Highlight Advances in Precision Medicine (September 6, 2015)

Today, September 6, the 16th World Conference on Lung Cancer (WCLC) begins in Denver, Colorado. The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. More... Continue Reading

Advanced Squamous Cell Lung Cancer: The Lung-MAP Trial (January 13, 2015)

The cancer research community is moving forward in its efforts find more effective treatment for patients with lung cancer. Current clinical trials are taking innovative approaches to how therapies for... Continue Reading

Innovative Clinical Trials for Lung Cancer Currently Underway (January 7, 2015)

The cancer research community is moving forward in its efforts find more effective treatment for patients with lung cancer. Current clinical trials are taking innovative approaches to how therapies for... Continue Reading

5 Things Women Should Know about Lung Cancer (December 3, 2014)

By Christina S. Baik, MD, MPH Assistant Professor, University of Washington School of Medicine Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center 1. Smoking causes the... Continue Reading

National Lung Cancer Awareness Month on CancerConnect (November 7, 2014)

November 7, 2014 Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of lung cancer programs for national lung cancer awareness month. As the month of November brings lung... Continue Reading

Study Using Comprehensive Genomic Tumor Testing to Match Lung Cancer Patients with Targeted Therapies Transforms Care (May 22, 2014)

Data Supports Routine Tumor Genotyping for Patients with Advanced Lung Cancers; May Improve Survival New data from a study led by Memorial Sloan Kettering physicians that used targeted therapy for patients... Continue Reading

Xgeva Improves Survival Over Zometa in Advanced Lung Cancer (November 28, 2012)

Patients with advanced lung cancer experienced modest improvement in survival when they received bone-targeted therapy with Xgeva® (denosumab) instead of Zometa® (zoledronic acid), according to the results... Continue Reading

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival... Continue Reading

November Is National Lung Cancer Awareness Month (November 4, 2009)

As the month of November brings lung cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options,... Continue Reading

Oral Hycamtin® Approved for Relapsed Small Cell Lung Cancer (October 15, 2007)

Oral Hycamtin® Approved for Relapsed Small Cell Lung Cancer The United States Food and Drug Administration (FDA) has approved an oral capsule formulation of the chemotherapy agent Hycamtin® (topotecan)... Continue Reading

Further Results Show Improved Survival with Picoplatin for Small Cell Lung Cancer (September 4, 2007)

Further Results Show Improved Survival with Picoplatin for Small Cell Lung Cancer According to results published in a press release by Poniard Pharmaceuticals, longer follow-up further indicates that the... Continue Reading

Addition of Gliadel® Wafer to Surgery and Radiation Effective for Brain Metastasis (June 22, 2007)

Addition of Gliadel® Wafer to Surgery and Radiation Effective for Brain Metastasis According to an article in Clinical Cancer Research, the addition of Gliadel® Wafer (carmustine polymer wafer) to surgery... Continue Reading

Hycamtin® Improves Survival in Patients with Relapsed Small Cell Lung Cancer (December 6, 2006)

Hycamtin® Improves Survival in Patients with Relapsed Small Cell Lung Cancer According to the results of a study published in the Journal of Clinical Oncology, patients with relapsed small cell lung cancer... Continue Reading

Amrubicin Shows Promise in Relapsed or Refractory Small Cell Lung Cancer (November 30, 2006)

Amrubicin Shows Promise in Relapsed or Refractory Small Cell Lung Cancer According to a study published in the Journal of Clinical Oncology, treatment with the experimental chemotherapy drug amrubicin... Continue Reading

Picoplatin May Improve Survival for Patients with Recurrent Small Cell Lung Cancer (November 7, 2006)

Picoplatin May Improve Survival for Patients with Recurrent Small Cell Lung Cancer According to results published in a press release by Poniard Pharmaceuticals, the investigative chemotherapy agent picoplatin... Continue Reading

PET Scans Help Re-Define Treatment Options for Small-Cell Lung Cancer (May 27, 2004)

PET Scans Help Re-Define Treatment Options for Small-Cell Lung Cancer According to a recent article published in the American Journal of Clinical Oncology, positron-emission tomography (PET) scans appear... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS